| To ensure that you never miss an issue, please whitelist us. |
|
|
| Recently, the United States Food and Drug Administration granted approval for Tzield (teplizumab-mzwv) injection: a groundbreaking treatment intended to obstruct the progression of stage 2 type 1 diabetes into its more serious form in adults as well as pediatric patients who are 8 years or older. |
|
|
Researchers assessed whether adherence to a Mediterranean diet pattern around the time of conception is associated with a lower risk for developing any APO. The analysis included 7,798 racially, ethnically, and geographically diverse women with singleton pregnancies who had complete diet data. |
| |
| |
| Colleagues examined patient values toward treatment goals and competing health outcomes among adults with well-differentiated, grade 1 or 2, advanced NETs. Sixty patients starting a new systemic therapy completed four tools: the Health Outcomes Tool; Attitude Scale; Now versus Later Tool; and Prognosis and Treatment Perceptions Questionnaire. |
| |
|
|
|